New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Depending on the patients' genotype, the same drug may have different efficacies or side effects. With the cost of genomic analysis decreasing and reliability of analysis methods improving, vast amount of genomic information has been made available. Several studies in pharmacology have been bas...
Saved in:
Main Authors: | Young Kyung Ko (Author), Jeong-An Gim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing variants related to chronic diseases from genome-wide association study (GWAS) and the cancer genome atlas (TCGA)
by: Soohyun Jeon, et al.
Published: (2023) -
Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region
by: Mohammed S. Alasmari, et al.
Published: (2024) -
Applied genomic in cerebrovascular disease
by: Hugo Sánchez Hernández, et al.
Published: (2018) -
Opportunities and challenges for applying model‐informed drug development approaches to gene therapies
by: Artur Belov, et al.
Published: (2021) -
Informing the Design of Direct-to-Consumer Interactive Personal Genomics Reports
by: Shaer, Orit, et al.
Published: (2015)